statistiche ricercatore

Continente	#
NA - Nord America	927
AS - Asia	492
EU - Europa	383
SA - Sud America	163
OC - Oceania	63
Continente sconosciuto - Info sul continente non disponibili	40
AF - Africa	17
Totale	2.085

Nazione	#
US - Stati Uniti d'America	886
SG - Singapore	187
IT - Italia	137
BR - Brasile	131
VN - Vietnam	96
CN - Cina	69
AU - Australia	63
RU - Federazione Russa	51
DE - Germania	42
GB - Regno Unito	29
FI - Finlandia	24
FR - Francia	24
CA - Canada	17
IN - India	17
BD - Bangladesh	16
HK - Hong Kong	16
KR - Corea	16
MX - Messico	16
AR - Argentina	15
JP - Giappone	13
NL - Olanda	13
SE - Svezia	13
ID - Indonesia	10
IQ - Iraq	8
LV - Lettonia	8
ES - Italia	6
JO - Giordania	6
ZA - Sudafrica	6
AT - Austria	5
CO - Colombia	5
EC - Ecuador	5
IE - Irlanda	5
MY - Malesia	5
PK - Pakistan	5
UA - Ucraina	5
DK - Danimarca	4
LK - Sri Lanka	4
PL - Polonia	4
TH - Thailandia	4
TR - Turchia	4
CL - Cile	3
JM - Giamaica	3
KE - Kenya	3
KZ - Kazakistan	3
PH - Filippine	3
BE - Belgio	2
BG - Bulgaria	2
GY - Guiana	2
IL - Israele	2
IR - Iran	2
LT - Lituania	2
NG - Nigeria	2
SK - Slovacchia (Repubblica Slovacca)	2
TT - Trinidad e Tobago	2
AE - Emirati Arabi Uniti	1
AM - Armenia	1
BH - Bahrain	1
BO - Bolivia	1
CG - Congo	1
CZ - Repubblica Ceca	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
EE - Estonia	1
EG - Egitto	1
ET - Etiopia	1
GD - Grenada	1
HN - Honduras	1
KW - Kuwait	1
LI - Liechtenstein	1
LU - Lussemburgo	1
MA - Marocco	1
NP - Nepal	1
PT - Portogallo	1
TN - Tunisia	1
UZ - Uzbekistan	1
VE - Venezuela	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	2.046

Nome	#
Harnessing CRISPR technology for the treatment of cystic fibrosis	362
A highly specific SpCas9 variant is identified by in vivo screening in yeast	335
Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing	207
VSV-G-Enveloped Vesicles for Traceless Delivery of CRISPR-Cas9	184
Combination of lentiviral and genome editing technologies for the treatment of sickle cell disease	155
Functional rescue of F508del-CFTR through revertant mutations introduced by CRISPR base editing	139
Gene Therapy for Cystic Fibrosis: Progress and Challenges of Genome Editing	130
Generation of corrected hiPSC clones from a Cornelia de Lange Syndrome (CdLS) patient through CRISPR-Cas-based technology	121
Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells	108
CoCas9 is a compact nuclease from the human microbiome for efficient and precise genome editing	101
Functional restoration of a CFTR splicing mutation through RNA delivery of CRISPR adenine base editor	91
Prime editing functionally corrects cystic fibrosis-causing CFTR mutations in human organoids and airway epithelial cells	89
Base-editing-mediated dissection of a γ-globin cis-regulatory element for the therapeutic reactivation of fetal hemoglobin expression	63
Totale	2.085

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	105	0	7	1	5	3	12	6	17	8	9	17	20
2022/2023	133	24	14	9	18	14	18	2	9	16	0	5	4
2023/2024	114	5	4	5	3	7	16	1	6	1	9	26	31
2024/2025	350	30	11	22	46	32	23	4	20	31	49	39	43
2025/2026	1.072	79	118	125	190	130	72	99	31	83	64	47	34
2026/2027	87	48	39	0	0	0	0	0	0	0	0	0	0
Totale													2.085